You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Crohn's Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

IBD, IBD, Crohn Disease Trial in Tel Aviv (photobiomodulation treatment in the infrared (IR) range.)

Recruiting
  • IBD
  • +2 more
  • photobiomodulation treatment in the infrared (IR) range.
  • Tel Aviv, Israel
    Dep. of Gastroenterology, Tel Aviv Sourasky Medical Center
Nov 19, 2023

Early Bowel Resection for Terminal Ileal Crohn's Disease

Recruiting
  • Crohn Disease
    • Sheffield, United Kingdom
      Sheffield Teaching Hospitals NHS Foundation Trust
    Oct 30, 2023

    Crohn's Disease Trial (MR Enterography (MRE))

    Not yet recruiting
    • Crohn's Disease
    • MR Enterography (MRE)
    • (no location specified)
    Nov 13, 2023

    Crohn Disease, Infliximab, Perianal Fistula Due to Crohn's Disease Trial (TDM-based infliximab intravenous therapy, Standard

    Not yet recruiting
    • Crohn Disease
    • +4 more
    • TDM-based infliximab intravenous therapy
    • Standard infliximab intravenous therapy
    • (no location specified)
    Sep 26, 2023

    Crohn Disease Trial in Roma (multimodal ultrasound)

    Recruiting
    • Crohn Disease
    • multimodal ultrasound
    • Roma, Italy
      Fondazione Policlinico Gemelli IRCCS
    Sep 25, 2023

    Irritable Bowel Syndrome-like Symptoms, Crohn Disease Remission Trial (BK003, Placebo)

    Not yet recruiting
    • Irritable Bowel Syndrome-like Symptoms
    • Crohn Disease Remission
    • BK003
    • Placebo
    • (no location specified)
    Oct 23, 2023

    Crohn Disease Trial in Besançon (Kono-S anastomosis, Conventional anastomosis for ileocolonicresection of Crohn's disease)

    Not yet recruiting
    • Crohn Disease
    • Kono-S anastomosis
    • Conventional anastomosis for ileocolonicresection of Crohn's disease
    • Besançon, France
      CHu de Besançon
    Jul 26, 2023

    Crohn Disease Trial in Beijing (Infliximab)

    Not yet recruiting
    • Crohn Disease
    • Beijing, China
      Beijing Children's Hospital, Capital Medical University
    Jun 13, 2023

    Crohn Disease, Pediatric Crohns Disease Trial in Bron (Blood samples, Biopsies)

    Not yet recruiting
    • Crohn Disease
    • Pediatric Crohns Disease
    • Blood samples
    • Biopsies
    • Bron, France
      Service Hépatologie, Gastroentérologie et Nutrition pédiatrique,
    Apr 24, 2023

    Crohn Disease Trial (RVT-3101)

    Not yet recruiting
    • Crohn Disease
    • (no location specified)
    Jun 9, 2023

    Insomnia, Crohn Disease Trial in Lebanon (Behavioral Treatment, Sleep Education Treatment)

    Not yet recruiting
    • Insomnia
    • Crohn Disease
    • Behavioral Treatment
    • Sleep Education Treatment
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Jul 13, 2023

    Ulcerative Colitis, Crohn's Disease Trial (Vedolizumab IV, Vedolizumab SC)

    Not yet recruiting
    • Ulcerative Colitis
    • Crohn's Disease
    • Vedolizumab IV
    • Vedolizumab SC
    • (no location specified)
    Oct 17, 2023

    Mesenteric Bacterial Translocation in Evolved Crohn's Disease

    Recruiting
    • Crohn Disease
      • Terrassa, Barcelona, Spain
        Hospital Universitari MútuaTerrassa
      May 26, 2023

      Fate in Fistulizing Crohn's Disease in a Pediatric Population

      Active, not recruiting
      • Crohn Disease
      • (no location specified)
      Feb 25, 2023

      Inflammatory Bowel Disease (IBD) Trial (Oxygen Gas for Inhalation, Standard of care)

      Not yet recruiting
      • Inflammatory Bowel Disease (IBD)
      • Oxygen Gas for Inhalation
      • Standard of care
      • (no location specified)
      Nov 2, 2023

      Crohn Disease Trial in Santiago de Compostela (MBF-018 oral capsules)

      Recruiting
      • Crohn Disease
      • MBF-018 oral capsules
      • Santiago de Compostela, Galicia, Spain
        Hospital Clínico Universitario de Santiago de Compostela
      Jul 7, 2023

      Crohn's Disease Trial (Risankizumab SC, Placebo for risankizumab)

      Not yet recruiting
      • Crohn's Disease
      • Risankizumab SC
      • Placebo for risankizumab
      • (no location specified)
      Sep 26, 2023

      Ustekinumab Among Bio-naive Crohn's Disease in China

      Not yet recruiting
      • Crohn Disease
      • Hangzhou, Zhejiang, China
      • +2 more
      Oct 9, 2023

      Crohn Disease, Ultrasound Therapy; Complications, Computed Tomography Trial in Hyderabad (Small intestinal contrast enhanced

      Recruiting
      • Crohn Disease
      • +3 more
      • Small intestinal contrast enhanced ultrasound followed by Computed tomography/Magnetic resonance enterography
      • Hyderabad, Telangana, India
        Asian Institute of Gastroenterology
      Nov 5, 2023

      Disease Activity and Adverse Events in Adolescent and Adult

      Recruiting
      • Crohn's Disease
        • Toyota-shi, Aichi, Japan
        • +1 more
        Aug 29, 2023

        Exclusive Enteral Nutrition in Adult Active Crohn's Disease

        Completed
        • Crohn's Disease
        • exclusive enteral nutrition treatment group
        • (no location specified)
        Apr 14, 2023

        Ustekinumab in Treatment of Crohn's Disease

        Completed
        • Ustekinumab
        • +3 more
          • Wenzhou, Zhejiang, China
            SAHWenzhouMU
          May 18, 2023

          Crohn's Disease Trial in Stockholm (AZD7798, [11C]AZ14132516)

          Not yet recruiting
          • Crohn's Disease
          • Stockholm, Sweden
            Research Site
          Sep 22, 2023

          Crohn Disease Trial in New York (Kono-S anastomosis (KSa), Side-to-side anastomosis (SSa))

          Not yet recruiting
          • Crohn Disease
          • Kono-S anastomosis (KSa)
          • Side-to-side anastomosis (SSa)
          • New York, New York
            Weill Cornell Medical Center
          Nov 17, 2023

          Unveiling the Microbial Impact on Intestinal Fibrosis

          Not yet recruiting
          • Crohn Disease
          • Surgical specimens of CD and no-IBD patients
          • Milan, Italy
            IRCCS Ospedale San Raffaele
          Oct 2, 2023